None listed
Conditions
Interventions
Sponsors
Morinaga & Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Japanese males and females aged 40-74 years when informed consent. 2) Individuals with feelings of lower back pain on a daily basis and who are judged by an orthopedic surgeon as not requiring immediate treatment. 3) Individuals who have received enough explanation and understood about this study, and who can obtain informed consent. 4) Individuals who do not suffer from specified disease and who do not receive medical treatment, medication, or treatment and judged appropriate for the study by the principal. 5) Individuals with a BMI >= 18.5 and <=29.9
Exclusion criteria
Exclusion criteria: Individuals 1) using medical products. 2) who have a history of serious hepatopathy, kidney damage, heart disease, lung and blood disease. 3) who have a history of serious gastrointestinal disease. 4) who used or applied a drug for treatment of disease in the past 1 month. 5) who have joint pain due to rheumatism or gout. 6) who have undergone or need lower back surgery. 7) who have a history of lumbar fracture, acute low back pain, intervertebral disk herniation, or spinal stenosis. 8) who have received treatment of block injection in the lower back within 1 year, or will receive it during this test period. 9) whose BMI is < 18.5 or >= 30 10) who have an irregular work pattern or perform physical labor. 11) who engage in strenuous exercise. 12) who regularly engage in activities that may affect the efficacy evaluation. 13) who are heavy alcohol drinker. 14) who regularly use a cane, a supporter of the low back or a corset. 15) who regularly use drugs (including external medicine) or ingest health-promoting foods, foods for specified health uses, health foods, or supplements that have the function of improving joints and muscles in the past 3 months or will use or ingest them during the test period. 16) who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplements containing ingredients of the test food in the past 3 months or will ingest them during the test period. 17) who participated in other clinical studies in the past 4 weeks, or will participate during this test period. 18) who are allergic to foods or medicines. 19) who are a smoker. 20) who are or are possibly pregnant, or are lactating. 21) who were hospitalized and received treatment in the past 6 months. 22) who will change life style during the test period. 23) who judged inappropriate for this study by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| JLEQ | — |
Countries
Japan
Contacts
Public ContactEriko Saito
Morinaga & Co., Ltd. Health Science and Research Center, R&D institute
Outcome results
None listed